Filing Details

Accession Number:
0001179110-10-005563
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-17 13:00:00
Reporting Period:
2010-03-15
Filing Date:
2010-03-17
Accepted Time:
2010-03-17 19:02:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419579 Anne-Marie Duliege C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-15 2,500 $0.80 2,500 No 4 M Direct
Common Stock Acquisiton 2010-03-15 3,000 $0.80 5,500 No 4 M Direct
Common Stock Acquisiton 2010-03-15 5,000 $4.36 10,500 No 4 M Direct
Common Stock Acquisiton 2010-03-15 11,083 $10.99 21,583 No 4 M Direct
Common Stock Disposition 2010-03-15 21,583 $20.88 0 No 4 S Direct
Common Stock Acquisiton 2010-03-16 2,500 $0.80 2,500 No 4 M Direct
Common Stock Disposition 2010-03-16 2,500 $20.96 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-03-15 2,500 $0.00 2,500 $0.80
Common Stock Stock Option (Right to Buy) Disposition 2010-03-15 3,000 $0.00 3,000 $0.80
Common Stock Stock Option (Right to Buy) Disposition 2010-03-15 5,000 $0.00 5,000 $4.36
Common Stock Stock Option (Right to Buy) Disposition 2010-03-15 11,083 $0.00 11,083 $10.99
Common Stock Stock Option (Right to Buy) Disposition 2010-03-16 2,500 $0.00 2,500 $0.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,500 2014-08-04 No 4 M Direct
0 2014-12-14 No 4 M Direct
5,000 2016-02-09 No 4 M Direct
26,917 2019-01-14 No 4 M Direct
0 2014-08-04 No 4 M Direct
Footnotes
  1. Shares were sold pursuant to a 10b5-1 Plans.
  2. The shares were sold at prices between $20.80 and $20.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each price.
  3. The option is immediately exercisable, but subject to the following vesting schedule: 1/4th of the shares vest one year after the vesting commencement date; the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.
  4. The option is immediately exercisable but subject to the following vesting schedule: The shares vest in a series of forty-eight (48) successive equal monthly installments over a four year period measured from the vesting commencement date.
  5. The shares issuable pursuant to the option vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from January 1, 2009.